New combo therapy tested in kids battling tough cancers

NCT ID NCT05255601

Completed Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

Summary

This early-stage study tested a new combination of two immunotherapy drugs (relatlimab and nivolumab) in children and young adults whose Hodgkin or non-Hodgkin lymphoma had come back or did not respond to standard treatments. The main goals were to find a safe dose and see if the treatment showed early signs of helping to control the cancer. Only 5 participants were enrolled to carefully check for side effects and how the drugs behaved in the body.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Assistance Publique-Hopitaux de Paris (AP-HP) - Hopital Armand-Trousseau

Paris, 75571, France
Assistance Publique-Hopitaux de Paris AP-HP - Hopital Universitaire Robert-Debre

Paris, 75935, France
Azienda Ospedale Universita Padova

Padua, 35128, Italy
Azienda Ospedaliero Universitaria di Bologna

Bologna, 40138, Italy
CHRU de Strasbourg-Hopital de Hautepierre

Strasbourg, 67000, France
CHU dAngers - Pole Pediatrie

Angers, Angers Cedex 9, 49933, France
Centre Hospitalier Universitaire de Montpellier CHU Montpellier - Hopital Arnaud de Villeneuve

Montpellier, 34295, France
Fondazione IRCCS Istituto Nazionale Dei Tumori

Milan, Milano, 20133, Italy
Fondazione MBBM - Clinica Pediatrica

Monza, 20900, Italy
Groupe Hospitalier Pellegrin - Hopital des enfants

Bordeaux, 33076, France
Institut d Hematologie et d Oncologie Pediatriques

Lyon, 69373 Cedex 08, France
Local Institution - 0002

Roma, 00165, Italy
Local Institution - 0004

Turin, 10126, Italy
Local Institution - 0010

Aviano, 33081, Italy
Local Institution - 0020

Jackson, Mississippi, 39216, United States
Local Institution - 0023

Seville, 41013, Spain
Local Institution - 0024

Phoenix, Arizona, 85016, United States
Local Institution - 0025

Minneapolis, Minnesota, 55454, United States
Local Institution - 0026

San Antonio, Texas, 78207, United States
Local Institution - 0029

Austin, Texas, 78723, United States
Local Institution - 0030

Madrid, 28009, Spain
Local Institution - 0032

New Haven, Connecticut, 06510, United States
Local Institution - 0033

Caen, 14033, France
Local Institution - 0035

Palo Alto, California, 94304, United States
Local Institution - 0037

Randwick, New South Wales, 2031, Australia
Local Institution - 0040

Florence, 50139, Italy
Local Institution - 0041

Pavia, 27100, Italy
Local Institution - 0042

Nedlands, Western Australia, 6009, Australia
Local Institution - 0044

Madrid, 28040, Spain
Local Institution - 0045

Madrid, 28046, Spain
Local Institution - 0046

Barcelona, 08035, Spain
Local Institution - 0049

Valencia, 46026, Spain
Local Institution - 0053

London, SM2 5PT, United Kingdom
Local Institution - 0054

London, Londonderry, NW1 2PG, United Kingdom
Local Institution - 0055

Madrid, 28041, Spain
Local Institution - 0058

Madrid, 28027, Spain
Local Institution - 0059

Valhalla, New York, 10595, United States
Local Institution - 0060

New York, New York, 10032, United States
Local Institution - 0062

Pamplona, 31008, Spain
Local Institution - 0066

Fort Myers, Florida, 33908, United States
Local Institution - 0067

La Tronche, 38700, France
Local Institution - 0068

Newcastle upon Tyne, Tyne and Wear, NE1 4LP, United Kingdom
Local Institution - 0069

Esplugues de Llobregat, Barcelona, 08950, Spain
Local Institution - 0070

Milan, 20162, Italy
Local Institution - 0071

Hackensack, New Jersey, 07601, United States
Local Institution - 0073

Baltimore, Maryland, 21287, United States
Local Institution - 0074

Liverpool, England, L12 2AP, United Kingdom
Local Institution - 0075

Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom
Local Institution - 0077

Birmingham, Alabama, 35233, United States
Princess Maxima Center for pediatric oncology

Utrecht, 3584 CS, Netherlands
Royal Childrens Hospital RCH - Queensland Childrens Hospital

South Brisbane, Queensland, 4101, Australia

Conditions

Explore the condition pages connected to this study.

HODGKIN DISEASE LYMPHOMA, NON-HODGKIN